impassion130: design and preliminary efficacy
Published 4 years ago • 69 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
4:47
tnbc: updated efficacy results from impassion130
-
4:33
i-o in tnbc: impassion130 trial design and results
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
2:33
applying impassion130 data to tnbc management
-
2:20
impassion130 and impassion131: the difference a taxane makes? | leisha emens
-
2:52
impassion130 study: improvement in os and pfs for iit and pd-l1 populations with mtnbc
-
4:27
the impassion130 study in metastatic tnbc
-
4:15
impassion130: atezolizumab (atezo) nab-paclitaxel (nab-p) vs placebo nab-p in treatment-naiv...
-
4:49
tecentriq demonstration
-
1:50:21
webinar - cáncer de mama axila positiva y plataformas genómicas (rxponder)
-
12:45
keynote-355: first-line pembrolizumab plus chemotherapy for metastatic triple-negative breast ca...
-
4:27
analysis of impassion130: pd-l1 testing in advanced tnbc
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
1:00
impassion130: implications
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
2:44
impassion130: addressing immune-related aes in tnbc management
-
2:14
mechanism of action of eftilagimod alpha for the treatment of breast cancer
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
4:53
results from the impassion130 trial for triple-negative breast cancer
-
5:28
evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...